obesity drug news today glp-1 Study predicts 16 new drugs may come to market Weight loss with GLP-1 medicines
Description
Peripheral insulin and amylin levels in Parkinsons disease
For those misusing opioids, the overdose finding is particularly significant
Mendelian randomization studies suggest reduced risks of schizophrenia, bipolar disorder, PTSD, and eating disorders in individuals treated with GLP-1RAs (203)
Pharmacologic Therapy for Obesity
Association of glp-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes
